FDA Approved: SOVUNA — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for SOVUNA (hydroxychloroquine sulfate) by ANI Pharmaceuticals, Inc., indicating a label change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Malaria
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• SOVUNA (Hydroxychloroquine sulfate)

Snippet

SUPPL AP for SOVUNA (HYDROXYCHLOROQUINE SULFATE)